ETORICOXIB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C18H15ClN2O2S
Molecular Weight	358.842
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of ETORICOXIB

Structure Search

SMILES

CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O

InChI

InChIKey=MNJVRJDLRVPLFE-UHFFFAOYSA-N

InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3

HIDE SMILES / InChI

Molecular Formula	C18H15ClN2O2S
Molecular Weight	358.842
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:48:16 UTC 2023` Edited by `admin` on `Fri Dec 15 15:48:16 UTC 2023`
Record UNII	WRX4NFY03R
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ETORICOXIB

Official Name

English

MK-0663

Code

English

ETORICOXIB [MI]

Common Name

English

5-CHLORO-6'-METHYL-3-(4-(METHYLSULFONYL)PHENYL)-2,3'-BIPYRIDINE

Systematic Name

English

ARCOXIA

Brand Name

English

ETORICOXIB [USAN]

Common Name

English

L-791456

Code

English

Etoricoxib [WHO-DD]

Common Name

English

ETORICOXIB [MART.]

Common Name

English

2,3'-BIPYRIDINE, 5-CHLORO-6'-METHYL-3-(4-(METHYLSULFONYL)PHENYL)-

Systematic Name

English

etoricoxib [INN]

Common Name

English

Classification Tree Code System Code

WHO-ATC

M01AH05

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

WHO-VATC

QM01AH05

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

NCI_THESAURUS

C1323

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

Code System Code Type Description

IUPHAR

2896

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

USAN

MM-46

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

SMS_ID

100000078581

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

DRUG CENTRAL

1113

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

ChEMBL

CHEMBL416146

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

PUBCHEM

123619

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

MERCK INDEX

m5200

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

Merck Index

EVMPD

SUB16429MIG

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

CAS

202409-33-4

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

INN

8082

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

NCI_THESAURUS

C52188

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

CHEBI

6339

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

WIKIPEDIA

ETORICOXIB

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

RXCUI

307296

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

RxNorm

FDA UNII

WRX4NFY03R

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

EPA CompTox

DTXSID3046457

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

DRUG BANK

DB01628

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

MESH

C422649

Created by admin on Fri Dec 15 15:48:16 UTC 2023 , Edited by admin on Fri Dec 15 15:48:16 UTC 2023

PRIMARY

Related Record Type Details


					8E4LAA4357

CYTOCHROME P450 2D6

METABOLIC ENZYME -> SUBSTRATE


					081I12ZA58

CYTOCHROME P450 2C19

METABOLIC ENZYME -> SUBSTRATE


					D8T754TT2I

COX-2

TARGET -> INHIBITOR

Interaction Type:

SELECTIVE


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE


					L9DP834D1P

CYTOCHROME P450 2C9

METABOLIC ENZYME -> SUBSTRATE


					WRX4NFY03R

EXCRETED UNCHANGED

Qualification:

URINE

Amount:


					VK4SQL11C0

CYTOCHROME P450 1A2

METABOLIC ENZYME -> SUBSTRATE

Related Record Type Details


					P2QB9XID3W

6'-METHYLHYDROXY ETORICOXIB N1'-OXIDE

METABOLITE -> PARENT

Comments:

FOLLOWING INTRAVENOUS ADMINISTRATION

Qualification:

URINE

Amount:


					8A0E1G55M9

6'-HYDROXYMETHYL ETORICOXIB

METABOLITE -> PARENT

Comments:

FOLLOWING INTRAVENOUS ADMINISTRATION

Qualification:

URINE

Amount:


					3G75T52B7D

6'-CARBOXY ETORICOXIB

METABOLITE -> PARENT

Comments:

FOLLOWING INTRAVENOUS ADMINISTRATION

Interaction Type:

MAJOR

Qualification:

URINE

Amount:


					FP09886CY9

ETORICOXIB-N1'-OXIDE

METABOLITE -> PARENT

Comments:

FOLLOWING INTRAVENOUS ADMINISTRATION

Qualification:

URINE

Amount:


					N5ED8OAI8F

6'-HYDROXYMETHYL-ETORICOXIB GLUCURONIDE

METABOLITE -> PARENT

Comments:

FOLLOWING INTRAVENOUS ADMINISTRATION

Qualification:

URINE

Amount:

Related Record Type Details


					9D65F147ZN

4-METHYLSULFONYLACETOPHENONE

IMPURITY -> PARENT


					C39I2W89XI

4-MESYLPHENYLACETIC ACID

IMPURITY -> PARENT


					X3ESZ1676P

2-CHLORO-1,3-BIS(DIMETHYLAMINO)TRIMETHINIUM HEXAFLUOROPHOSPHATE

IMPURITY -> PARENT


					YA0K0CM5PK

6-METHYL(PYRIDINE-3-CARBOXYLIC ACID)METHYL ESTER

IMPURITY -> PARENT


					RCYJMCPV68

1-(6-METHYLPYRIDIN-3-YL)-2-(4-(METHYLSULFONYL)PHENYL)ETHANONE

IMPURITY -> PARENT

Related Record Type Details


					WRX4NFY03R

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC				ORAL ADMINISTRATION ORAL SOLUTION DOSE

Tmax	PHARMACOKINETIC				ORAL SOLUTION DOSE ORAL ADMINISTRATION

ORAL BIOAVAILABILITY	PHARMACOKINETIC